(Reuters) – Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its COVID-19 antibody drug for $812.5 million.
The doses will be delivered through Jan. 31, with at least 350,000 delivered in December, the company said.
(Reporting by Dania Nadeem in Bengaluru; Editing by Sriraj Kalluvila)
